Differential effects of inhaled corticosteroids in smokers/ex-smokers and nonsmokers with asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 191, Issue 8, 2015, Pages 960-964

  Roche, Nicolas ^a,b   Postma, Dirkje S ^c   Colice, Gene ^d,e   Burden, Anne ^f   Guilbert, Theresa W ^g   Israel, Elliot ^h,i   Martin, Richard J ^j   Van Aalderen, Willem M C ^k   Grigg, Jonathan ^l   Hillyer, Elizabeth V ^f   Von Ziegenweidt, Julie ^f   Price, David B ^f,m  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d WASHINGTON HOSPITAL CENTER   (United States)

^e GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^f Research in Real Life Ltd   (United Kingdom)

^g CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

^j DEPARTMENT OF MEDICINE   (United States)

^k EMMA CHILDREN S HOSPITAL   (Netherlands)

^l QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^m UNIVERSITY OF ABERDEEN   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; CIGARETTE SMOKE; CORTICOSTEROID; FLUORINATED HYDROCARBON; ANDROSTANE DERIVATIVE; BECLOMETASONE; FLUTICASONE;

ADULT; AGED; ASTHMA; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EXPOSURE; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; LETTER; LOWER RESPIRATORY TRACT INFECTION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RHINITIS; SMOKING; TREATMENT RESPONSE; AGE DISTRIBUTION; COHORT ANALYSIS; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED; SMOKING CESSATION; TREATMENT OUTCOME; UNITED KINGDOM;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADULT; AGE DISTRIBUTION; AGED; ANDROSTADIENES; ASTHMA; BECLOMETHASONE; COHORT STUDIES; GREAT BRITAIN; HUMANS; MIDDLE AGED; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 84927794476     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201411-2116LE     Document Type: Letter

References (19)

1. Polosa R, Thomson NC. Smoking and asthma: dangerous liaisons. Eur Respir J 2013;41:716-726.
2. Tomlinson JE, McMahon AD, Chaudhuri R, Thompson JM, Wood SF, Thomson NC. Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax 2005;60: 282-287.
3. Thomson NC, Spears M. Asthma guidelines and smokers: it's time to be inclusive. Chest 2012;141:286-288.
4. Price D, Bjermer L, Popov TA, Chisholm A. Integrating evidence for managing asthma in patients who smoke. Allergy Asthma Immunol Res 2014;6:114-120.
5. Contoli M, Kraft M, Hamid Q, Bousquet J, Rabe KF, Fabbri LM, Papi A. Do small airway abnormalities characterize asthma phenotypes? In search of proof. Clin Exp Allergy 2012;42:1150-1160.
6. Strulovici-Barel Y, Omberg L, O'Mahony M, Gordon C, Hollmann C, Tilley AE, Salit J, Mezey J, Harvey BG, Crystal RG. Threshold of biologic responses of the small airway epithelium to low levels of tobacco smoke. Am J Respir Crit Care Med 2010;182:1524-1532.
7. van der Wiel E, ten Hacken NH, Postma DS, van den Berge M. Smallairways dysfunction associates with respiratory symptoms and clinical features of asthma: a systematic review. J Allergy Clin Immunol 2013;131:646-657.
8. Leach CL, Davidson PJ, Hasselquist BE, Boudreau RJ. Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone: a cross-over study in healthy volunteers. Chest 2002;122:510-516.
9. Cohen J, Postma DS, Douma WR, Vonk JM, De Boer AH, ten Hacken NH. Particle size matters: diagnostics and treatment of small airways involvement in asthma. Eur Respir J 2011;37:532-540.
10. Price D, Martin RJ, Milton-Edwards M, Israel E, Roche N, Burden A, von Ziegenweidt J, Gould SE, Hillyer E, Colice GL. Comparative effectiveness of extrafine hydrofluoroalkane beclomethasone (EF HFA-BDP) and fluticasone propionate (FP) in smoking asthmatic patients-a retrospective, real-life observational study in a UK primary care asthma population [abstract]. J Allergy Clin Immunol 2013;131:AB3.
11. Price D, Martin RJ, Milton-Edwards M, Israel E, Roche N, Burden A, von Ziegenweidt J, Gould SE, Hillyer E, Colice GL. Comparative effectiveness of extrafine hydrofluoroalkane beclometasone (EF HFABDP) and fluticasone propionate (FP) in smoking asthmatic patients-a retrospective, real-life observational study in a UK primary care asthma population [abstract]. Prim Care Respir J 2013;22:A8.
12. Clinical Practice Research Datalink. Welcome to The Clinical Practice Research Datalink [accessed 2014 Nov 24]. Available from: http://www.cprd.com/home/
13. Optimum Patient Care (OPC). OPC Home [accessed 2014 Nov 24]. Available from: http://www.optimumpatientcare.org/
14. Cripps A, Riebe M, Schulze M, Woodhouse R. Pharmaceutical transition to non-CFC pressurized metered dose inhalers. Respir Med 2000;94(Suppl B):S3-S9.
15. Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, et al.; American Thoracic Society/European Respiratory Society Task Force on Asthma Control and Exacerbations. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009;180:59-99.
16. Telenga ED, Kerstjens HA, Ten Hacken NH, Postma DS, van den Berge M. Inflammation and corticosteroid responsiveness in ex-, current- and never-smoking asthmatics. BMC Pulm Med 2013; 13:58.
17. Becklake MR, Lalloo U. The 'healthy smoker': a phenomenon of health selection? Respiration 1990;57:137-144.
18. Price D, Martin RJ, Barnes N, Dorinsky P, Israel E, Roche N, Chisholm A, Hillyer EV, Kemp L, Lee AJ, et al. Prescribing practices and asthma control with hydrofluoroalkane-beclomethasone and fluticasone: a real-world observational study. J Allergy Clin Immunol 2010;126:511-518.
19. Colice G, Martin RJ, Israel E, Roche N, Barnes N, Burden A, Polos P, Dorinsky P, Hillyer EV, Lee AJ, et al. Asthma outcomes and costs of therapy with extrafine beclomethasone and fluticasone. J Allergy Clin Immunol 2013;132:45-54.